ABEO
Abeona Therapeutics Inc.
$6.80
+0.25 (+3.82%)
At close · Jul 8
Market Cap
$387.57M
Shares
56,995,144
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.82M
FY2025
Net Income
$71.18M
+211.7%
FY2025
Gross Margin
73.68%
FY2025
Operating Margin
-1536.91%
FY2025
Diluted EPS
$1.01
+165.2%
FY2025
Operating Cash Flow
-$76.33M
-36.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $5.82M | — | $3.5M | $1.41M | $3M | $10M | — | $3M | $837K | $889K | $1.04M | $925K | $2.04M | $4.4M | $1.84M | $481K | |
| — | — | — | — | — | — | — | — | — | — | $2.35M | $2.52M | — | — | — | — | — | |
| — | $1.53M | — | — | — | — | — | — | — | — | — | — | $0 | $125K | $267K | $148K | $140K | |
| — | $4.29M | — | — | — | — | — | — | — | — | — | — | $925K | $1.92M | $4.14M | $1.69M | $341K | |
| — | 73.68% | — | — | — | — | — | — | — | — | — | — | 100% | 93.88% | 93.94% | 91.95% | 70.89% | |
| $26.43M | $26.81M | $34.36M | $31.09M | $28.97M | $38.73M | $30.14M | $48.57M | $38.7M | $16.99M | $10.66M | $4.72M | $333K | $884K | $2.01M | $3.58M | $3.35M | |
| — | $65.03M | $29.85M | $19M | $17.26M | $21.64M | $23.78M | $20.71M | $20.11M | $10.94M | $13.29M | $14.32M | $3.71M | — | — | $4.08M | $4.51M | |
| $74.75M | $65.03M | $29.85M | — | — | — | — | — | — | — | — | — | $3.71M | $4.83M | $6.02M | $5.76M | — | |
| $116K | — | — | — | — | $116K | $1.4M | $5.2M | $1.2M | $500K | $677K | $538K | $9000 | $0 | $362K | $212K | — | |
| $2.71M | $2.55M | $2M | $2.29M | $3.09M | $3.25M | $4.59M | $7.82M | $2.36M | $741K | $825K | $551K | $11K | $3000 | $419K | $233K | $238K | |
| $74.94M | — | $64.21M | $50.64M | $52.33M | $92.84M | $91.42M | $77.09M | $61.16M | $28.67M | — | — | — | — | — | — | — | |
| — | $95.27M | $64.21M | — | — | — | — | — | $61.16M | $28.67M | $24.77M | $19.59M | $4.06M | $5.85M | $8.72M | $9.72M | $8.24M | |
| -$92.75M | -$89.45M | -$64.21M | -$47.14M | -$50.92M | -$89.84M | -$81.42M | -$77.09M | -$58.17M | -$27.84M | -$23.88M | -$18.55M | -$3.13M | -$3.8M | -$4.32M | -$7.88M | -$7.76M | |
| — | -1536.91% | — | -1346.71% | -3600.78% | -2994.53% | -814.2% | — | -1940.16% | -3325.69% | -2686.28% | -1783.27% | -338.49% | -186.29% | -98% | -428.28% | -1612.68% | |
| -$90.05M | -$86.9M | -$62.21M | -$44.85M | -$47.82M | -$86.59M | -$76.83M | -$69.27M | -$55.81M | -$27.1M | -$23.06M | -$18M | -$3.12M | -$3.8M | -$3.9M | -$7.64M | -$7.52M | |
| $3.57M | $3.74M | $4.21M | $418K | $736K | $3.66M | $4.12M | — | — | — | — | — | — | — | — | — | — | |
| $319K | $410K | $1.19M | $2.94M | $141K | — | — | — | — | $517K | $2.01M | $4.02M | -$23.65M | $8.25M | -$6.22M | $5.36M | $220K | |
| $66.24M | $71.28M | -$63.73M | — | — | — | — | — | — | — | — | — | — | — | -$10.53M | -$2.52M | -$7.54M | |
| — | $100K | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $17K | $0 | |
| $66.14M | $71.18M | -$63.73M | -$54.19M | -$39.7M | -$84.94M | -$84.23M | -$76.28M | -$56.67M | -$27.32M | -$21.87M | -$14.53M | -$26.78M | $4.45M | -$10.53M | -$2.53M | -$7.54M | |
| — | 1223.08% | — | -1548.23% | -2807.36% | -2831.2% | -842.34% | — | -1890.29% | -3263.92% | -2460.4% | -1396.73% | -2894.92% | 217.87% | -239.15% | -137.68% | -1566.94% | |
| — | — | -$63.7M | -$54.2M | -$43.48M | -$84.94M | — | — | — | — | -$21.87M | -$14.53M | -$29.65M | $1.55M | -$12.53M | -$4.31M | -$9.33M | |
| $66.18M | $71.31M | -$63.66M | -$54.13M | -$43.58M | -$84.95M | -$84.24M | -$76.28M | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | $1.34 | -$1.55 | -$2.53 | -$5.53 | -$21.57 | — | — | — | — | — | — | -$381.50 | $76.75 | -$13.00 | — | — |
| USD/shares | — | $1.01 | -$1.55 | -$2.53 | -$5.53 | — | — | — | — | — | — | — | -$381.50 | $76.00 | -$13.00 | — | — |
| shares | — | 52.95M | 41.05M | 21.38M | 7.86M | 3.94M | 3.71M | 2.01M | 1.9M | 1.67M | 1.37M | 1.1M | 77.72K | 20.19K | 967.15K | 799.33K | — |
| shares | — | 66.14M | 41.05M | 21.38M | 7.86M | 3.94M | 3.71M | 2.01M | 1.9M | 1.67M | 1.37M | 1.1M | 77.72K | 20.38K | 967.15K | 799.33K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
7.16×
Biotechnology median 7.60×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|
| License | $3,400,000 | — | — |
| Product | $2,420,000 | — | — |
| License and Other Revenues | — | $3,000,000 | $10,000,000 |